Physician profile
Robert W Frank
NPI 1750640512
$4,283.07
in general payments reported to CMS, 2019-2025
21 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what 82% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $162 · 2021: $99.14 · 2022: $680 · 2023: $811 · 2024: $970 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,904.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,903.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $550.39 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $541.27 | 2019-2025 | Dupixent |
| Inspire Medical Systems, INC. | $476.96 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $454.85 | 2019-2025 | Nucala |
| Stryker Corporation | $439.71 | 2022-2025 | Xpress Ent Dilation System, Scopis Ent |
| Integra Lifesciences Corporation | $313.51 | 2022-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Genentech USA, INC. | $292.31 | 2019-2023 | Xolair |
| Aerin Medical INC. | $238.08 | 2024 | |
| Acclarent, INC | $209.34 | 2023-2024 | Acclarent Navwire, Acclarent Aera, Trudi Nav Cable |
| Novartis Pharmaceuticals Corporation | $194.14 | 2022-2024 | |
| Smith+Nephew, INC. | $107.64 | 2020-2025 | Coblation, Tula |
| Ars Pharmaceuticals Operations, INC. | $86.63 | 2025 | Neffy |
| Kaleo, INC. | $75.83 | 2019-2023 | Auvi-Q |
| Astrazeneca Pharmaceuticals LP | $71.27 | 2019-2025 | Fasenra |
| Hikma Pharmaceuticals USA | $54.06 | 2024-2025 | Ryaltris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $48.95 | 2023-2024 | Coolseal Generator |
| Optinose US, INC. | $39.16 | 2022-2025 | |
| Alk-Abello, INC | $38.80 | 2019-2025 | Timothy, Standardized, Alternaria Tenuis, Standardized Mite D. Farinae |
| Baxter Healthcare | $19.26 | 2025 | Perclot |
| Olympus America INC. | $16.22 | 2022 | |
| Neurent Medical Limited | $14.69 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Frank listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.